Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Elseviers, MM; De Broe, ME
   What can nephrologists learn from epidemiology?
   JOURNAL OF NEPHROLOGY
   
   M.M. Elseviers e M.E. De Broe, "What can nephrologists learn from epidemiology?", J NEPHROL, 14(2), 2001, pp. 88-92
2. Sturmer, T; Elseviers, MM; De Broe, ME
   Nonsteroidal anti-inflammatory drugs and the kidney
   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
   
   T. Sturmer et al., "Nonsteroidal anti-inflammatory drugs and the kidney", CURR OP NEP, 10(2), 2001, pp. 161-163
3. Lins, RL; Elseviers, M; Daelemans, R; De Broe, ME
   Problems in the development, validation and adaptation of prognostic models for acute renal failure
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   R.L. Lins et al., "Problems in the development, validation and adaptation of prognostic models for acute renal failure", NEPH DIAL T, 16(6), 2001, pp. 1098-1101
4. Verstrepen, WA; Persy, VP; Verhulst, A; Dauwe, S; De Broe, ME
   Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   W.A. Verstrepen et al., "Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat", NEPH DIAL T, 16(4), 2001, pp. 712-724
5. De Broe, ME
   Apoptosis in acute renal failure
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   M.E. De Broe, "Apoptosis in acute renal failure", NEPH DIAL T, 16, 2001, pp. 23-26
6. Leussink, BT; Slikkerveer, A; Engelbrecht, MRW; van der Voet, GB; Nouwen, EJ; de Heer, E; de Broe, ME; de Wolff, FA; Bruijn, JA
   Bismuth overdosing-induced reversible nephropathy in rats
   ARCHIVES OF TOXICOLOGY
   
   B.T. Leussink et al., "Bismuth overdosing-induced reversible nephropathy in rats", ARCH TOXIC, 74(12), 2001, pp. 745-754
7. Daelemans, RA; D'Haese, PC; De Broe, ME
   Dialysis
   SEMINARS IN NEPHROLOGY
   
   R.A. Daelemans et al., "Dialysis", SEM NEPHROL, 21(2), 2001, pp. 204-212
8. De Greef, KE; Ysebaert, DK; Dauwe, S; Persy, V; Vercauteren, SR; Mey, D; De Broe, ME
   Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia
   KIDNEY INTERNATIONAL
   
   K.E. De Greef et al., "Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia", KIDNEY INT, 60(4), 2001, pp. 1415-1427
9. Bosmans, JL; Holvoet, P; Dauwe, SEH; Ysebaert, DK; Chapelle, T; Jurgens, A; Kovacic, V; Van Marck, EA; De Broe, ME; Verpooten, GA
   Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years
   KIDNEY INTERNATIONAL
   
   J.L. Bosmans et al., "Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years", KIDNEY INT, 59(6), 2001, pp. 2346-2356
10. Elseviers, MM; De Broe, ME
    Relationship between nonphenacetin-combined analgesics and nephropathy
    KIDNEY INTERNATIONAL
    
    M.M. Elseviers e M.E. De Broe, "Relationship between nonphenacetin-combined analgesics and nephropathy", KIDNEY INT, 59(6), 2001, pp. 2370-2370
11. Helbert, MJF; Dauwe, SEH; De Broe, ME
    Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system
    KIDNEY INTERNATIONAL
    
    M.J.F. Helbert et al., "Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system", KIDNEY INT, 59(2), 2001, pp. 554-564
12. D'Haese, PC; De Broe, ME
    Aluminium and iron: Implications for Alzheimer's disease
    ALUMINIUM AND ALZHEIMER'S DISEASE: THE SCIENCE THAT DESCRIBES THE LINK
    
    P.C. D'Haese e M.E. De Broe, "Aluminium and iron: Implications for Alzheimer's disease", ALUMINIUM AND ALZHEIMER'S DISEASE: THE SCIENCE THAT DESCRIBES THE LINK, 2001, pp. 221-231
13. Smans, KA; D'Haese, PC; Van Landeghem, GF; Andries, LJ; Lamberts, LV; Hendy, GN; De Broe, ME
    Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    K.A. Smans et al., "Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion", NEPH DIAL T, 15(9), 2000, pp. 1328-1336
14. Ysebaert, DK; De Greef, KE; Vercauteren, SR; Ghielli, M; Verpooten, GA; Eyskens, EJ; De Broe, ME
    Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    D.K. Ysebaert et al., "Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury", NEPH DIAL T, 15(10), 2000, pp. 1562-1574
15. Woestenburg, AT; Mensch, PP; Bosmans, JL; Elseviers, MM; Verpooten, GA; De Broe, ME
    Morphometric analysis of renal vessels - Advantage of the multisector areaapproach to cross-sections
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    
    A.T. Woestenburg et al., "Morphometric analysis of renal vessels - Advantage of the multisector areaapproach to cross-sections", ANAL QUAN C, 22(4), 2000, pp. 285-290
16. Lins, RL; Elseviers, M; Daelemans, R; Zachee, P; Gheuens, E; Lens, S; De Broe, ME
    Prognostic value of a new scoring system for hospital mortality in acute renal failure
    CLINICAL NEPHROLOGY
    
    R.L. Lins et al., "Prognostic value of a new scoring system for hospital mortality in acute renal failure", CLIN NEPHR, 53(1), 2000, pp. 10-17
17. Ghielli, M; Verstrepen, WA; De Greef, KEJ; Helbert, MH; Ysebaert, DK; Nouwen, EJ; De Broe, ME
    Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury. (vol 58, pg 1121, 2000)
    KIDNEY INTERNATIONAL
    
    M. Ghielli et al., "Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury. (vol 58, pg 1121, 2000)", KIDNEY INT, 58(5), 2000, pp. 2257-2257
18. Ghielli, M; Verstrepen, WA; De Greef, KEJ; Helbert, MH; Ysebaert, DK; Nouwen, EJ; De Broe, ME
    Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury
    KIDNEY INTERNATIONAL
    
    M. Ghielli et al., "Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury", KIDNEY INT, 58(3), 2000, pp. 1121-1134
19. Duymelinck, C; Dauwe, SEH; De Greef, KEJ; Ysebaert, DK; Verpooten, GA; De Broe, ME
    TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat
    KIDNEY INTERNATIONAL
    
    C. Duymelinck et al., "TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat", KIDNEY INT, 58(3), 2000, pp. 1186-1201
20. D'Haese, PC; Schrooten, I; Goodman, WG; Cabrera, WE; Lamberts, LV; Elseviers, MM; Couttenye, MM; De Broe, ME
    Increased bone strontium levels in hemodialysis patients with osteomalacia
    KIDNEY INTERNATIONAL
    
    P.C. D'Haese et al., "Increased bone strontium levels in hemodialysis patients with osteomalacia", KIDNEY INT, 57(3), 2000, pp. 1107-1114
21. Bosmans, JL; Woestenburg, AT; Helbert, MJ; Ysebaert, DK; Van Marck, E; De Broe, ME; Verpooten, GA
    Impact of donor-related vascular alterations in implantation biopsies on morphologic and functional outcome of cadaveric renal allografts
    TRANSPLANTATION PROCEEDINGS
    
    J.L. Bosmans et al., "Impact of donor-related vascular alterations in implantation biopsies on morphologic and functional outcome of cadaveric renal allografts", TRANSPLAN P, 32(2), 2000, pp. 379-380
22. Bosmans, JL; Woestenburg, A; Ysebaert, DK; Chapelle, T; Helbert, MJ; Corthouts, R; Jurgens, A; Van Daele, A; Van Marck, EA; De Broe, ME; Verpooten, GA
    Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts
    TRANSPLANTATION
    
    J.L. Bosmans et al., "Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts", TRANSPLANT, 69(11), 2000, pp. 2388-2394
23. Vercauteren, SR; Ysebaert, DK; De Greef, KE; Eyskens, EJ; De Broe, ME
    Chronic reduction in renal mass in the rat attenuates ischemia/reperfusioninjury and does not impair tubular regeneration
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    S.R. Vercauteren et al., "Chronic reduction in renal mass in the rat attenuates ischemia/reperfusioninjury and does not impair tubular regeneration", J AM S NEPH, 10(12), 1999, pp. 2551-2561
24. De Broe, ME; Helbert, MJF
    Biology of renal tubulo-interstitial cells
    EXPERIMENTAL NEPHROLOGY
    
    M.E. De Broe e M.J.F. Helbert, "Biology of renal tubulo-interstitial cells", EXP NEPHROL, 7(5-6), 1999, pp. 341-343
25. Helbert, MJF; Dauwe, S; De Broe, ME
    Flow cytometric immunodissection of the human nephron in vivo and in vitro
    EXPERIMENTAL NEPHROLOGY
    
    M.J.F. Helbert et al., "Flow cytometric immunodissection of the human nephron in vivo and in vitro", EXP NEPHROL, 7(5-6), 1999, pp. 360-376
26. Behets, GJ; De Broe, ME
    SDS-electrophoresis of unconcentrated urine samples using a semi-automaaicmethod
    RENAL FAILURE
    
    G.J. Behets e M.E. De Broe, "SDS-electrophoresis of unconcentrated urine samples using a semi-automaaicmethod", RENAL FAIL, 21(3-4), 1999, pp. 409-412
27. Cabrera, WE; Schrooten, I; De Broe, ME; D'Haese, PC
    Strontium and bone
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    W.E. Cabrera et al., "Strontium and bone", J BONE MIN, 14(5), 1999, pp. 661-668
28. Van Hoof, VO; Couttenye, MM; Van Brussel, KA; Wendelen, LC; Waegemans, SE; De Broe, ME
    Biochemical evaluation of bone metabolism in dialysis patients
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    V.O. Van Hoof et al., "Biochemical evaluation of bone metabolism in dialysis patients", NIEREN HOCH, 28(10), 1999, pp. 402-406
29. De Broe, ME
    On a nephratoxic and carcinogenic slimming regimen
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    M.E. De Broe, "On a nephratoxic and carcinogenic slimming regimen", AM J KIDNEY, 33(6), 1999, pp. 1171-1173
30. De Broe, ME; De Weerdt, DL; Ysebaert, DK; Vercauteren, SR; De Greef, KE; De Broe, LC
    The low countries - 16th/19th century
    AMERICAN JOURNAL OF NEPHROLOGY
    
    M.E. De Broe et al., "The low countries - 16th/19th century", AM J NEPHR, 19(2), 1999, pp. 282-289
31. Elseviers, MM; De Broe, ME
    Analgesic nephropathy - Is it caused by multi-analgesic abuse or single substance use?
    DRUG SAFETY
    
    M.M. Elseviers e M.E. De Broe, "Analgesic nephropathy - Is it caused by multi-analgesic abuse or single substance use?", DRUG SAFETY, 20(1), 1999, pp. 15-24
32. Schrooten, I; Elseviers, MM; Lamberts, LV; de Broe, ME; D'Haese, PC
    Increased serum strontium levels in dialysis patients: An epidemiological survey
    KIDNEY INTERNATIONAL
    
    I. Schrooten et al., "Increased serum strontium levels in dialysis patients: An epidemiological survey", KIDNEY INT, 56(5), 1999, pp. 1886-1892
33. Persy, VP; Verstrepen, WA; Ysebaert, DK; De Greef, KE; De Broe, ME
    Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion
    KIDNEY INTERNATIONAL
    
    V.P. Persy et al., "Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion", KIDNEY INT, 56(2), 1999, pp. 601-611
34. Couttenye, MM; D'Haese, PC; Verschoren, WJ; Behets, GJ; Schrooten, I; De Broe, ME
    Low bone turnover in patients with renal failure
    KIDNEY INTERNATIONAL
    
    M.M. Couttenye et al., "Low bone turnover in patients with renal failure", KIDNEY INT, 56, 1999, pp. S70-S76
35. Vercauteren, SR; Bosmans, JL; Elseviers, MM; Verpooten, GA; De Broe, ME
    Cyclosporine-induced nephrotoxicity in autoimmune diseases - Reply
    KIDNEY INTERNATIONAL
    
    S.R. Vercauteren et al., "Cyclosporine-induced nephrotoxicity in autoimmune diseases - Reply", KIDNEY INT, 55(5), 1999, pp. 2075-2076
36. Heuvels, J; Maximus, A; Bosmans, JL; Lambert, J; De Broe, ME
    Renal abnormalities in psoriatic patients: A review
    NEPHRON
    
    J. Heuvels et al., "Renal abnormalities in psoriatic patients: A review", NEPHRON, 82(1), 1999, pp. 1-6
37. D'Haese, PC; Couttenye, MM; Lamberts, LV; Elseviers, MM; Goodman, WG; Schrooten, I; Cabrera, WE; De Broe, ME
    Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients
    CLINICAL CHEMISTRY
    
    P.C. D'Haese et al., "Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients", CLIN CHEM, 45(9), 1999, pp. 1548-1556
38. Couttenye, MM; D'Haese, PC; De Broe, ME
    What considerations should we give to adynamic bone disease?
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    
    M.M. Couttenye et al., "What considerations should we give to adynamic bone disease?", INT J ARTIF, 21(11), 1998, pp. 687-692
39. Calomme, MR; Cos, P; D'Haese, PC; Vingerhoets, R; Lamberts, LV; De Broe, ME; Van Hoorebeke, C; Vanden Berghe, DA
    Absorption of silicon in healthy subjects
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 5
    
    M.R. Calomme et al., "Absorption of silicon in healthy subjects", MET ION BIO, 5, 1998, pp. 228-232